Applied Biosystems to webcast SOLiD session during genetics meeting

Applied Biosystems has announced plans to webcast a meeting with investors this week.

The one-hour question and answer session during the American Society of Human Genetics (ASHG) annual meeting in San Diego takes place on Thursday morning.

Kimberlee Caple, vice president and general manager of the firm’s High-Throughput Discovery business unit which has developed its SOLiD next-generation DNA sequencing system, intends to field questions from the audience.

With commercial shipments beginning earlier this month, Applied Biosystems has sought to "set the standard in next-generation technology" with the SOLiD System.

A company spokesperson described the system as "the only platform to provide the accuracy, throughput and scalability required to enable exciting new applications beyond the boundaries of traditional genetic analysis."

"The company that automated sequencing now introduces a genomic platform with the power to break the barriers into a new generation of discovery," the spokesperson concluded.

Applied Biosystems serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services.

Its customers use these tools to analyse nucleic acids (DNA and RNA), small molecules and proteins to make scientific discoveries and develop new pharmaceuticals.